FDA clears first gene-altering therapy — ‘ a living drug ’ — for childhood leukemia

The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' genetically altered immune cells to fight the disease. It is the first gene therapy to be cleared in the United States — a “historic” action, the agency said -- and one with major ramifications for patients with […]Related:FDA cracks down on stem-cell clinics, including one using smallpox vaccine in cancer patientsDoes talcum powder cause ovarian cancer?NIH unit deletes references to climate ‘change’
Source: Washington Post: To Your Health - Category: Consumer Health News Source Type: news